Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
TCR
2:30
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma
Angela Krackhard
• 6 Apr 2022
4:27
Developing individualized cancer therapies with neoantigen-specific TCRs
Angela Krackhard
• 6 Apr 2022
5:33
Improving immune-imaging tools to assess cancer immunotherapies
Angela Krackhard
• 6 Apr 2022
2:04
Targeting WT1 peptides for TCR-based AML therapy
Chiara Bonini
• 1 Apr 2022
1:46
TCR redirected T cells for cancer therapy
Chiara Bonini
• 1 Apr 2022
0:55
The use of CRISPR-Cas9 technology in the development of T cell therapies
Alessio Nahmad
• 31 Mar 2022
2:17
Accelerating the identification of clinically relevant T cell therapies
Elvira D’Ippolito
• 31 Mar 2022
3:02
Genome editing to address challenges with adoptive T-cell therapy
Chiara Bonini
• 22 Nov 2021
4:17
miCAR: combining microRNA gene silencing with CAR expression
Marco Alessandrini
• 20 May 2021
4:08
Characterization of ATA188: an off-the-shelf therapy for MS
Jakob Dupont
• 17 Jun 2021
3:06
Targeting solid tumors: SPEAR T-cells & HLA-independent TCRs
Jo Brewer
• 7 Apr 2021
6:05
Selecting TCRs: understanding peptide-HLA-TCR interactions
Dolores Schendel
• 25 Feb 2021
3:23
How the TCR field can learn from CARs
Dolores Schendel
• 25 Feb 2021
5:11
PD1-41BB switch receptor expression in the treatment of PD-L1-positve solid tumors
Dolores Schendel
• 25 Feb 2021
1:48
CAR-TCR Europe highlights: synthetic biology & the autologous vs allogeneic debate
Dalip Sethi
• 23 Feb 2021